Literature DB >> 8982371

Cryoablation for carcinoma of the prostate.

B G Patel1, C L Parsons, M Bidair, J D Schmidt.   

Abstract

Percutaneous transperineal cryoablation of the prostate is now available in the armamentarium for treatment of prostate cancer. Technical advances in real-time transrectal imaging of the prostate and improvements in cryosurgical equipment have brought this modality into the limelight of available prostate cancer management. Cryosurgery can be offered to many patients with prostate cancer. However, the main indications for its use include primary treatment for localized disease, salvage therapy after failure of traditional methods, and relief of local symptoms. A historical background, description of the technique, and clinical experience at several medical centers including the University of California San Diego, Allegheny General Hospital, University of Texas M.D. Anderson Cancer Center, and Crittenton Hospital, are presented.

Entities:  

Mesh:

Year:  1996        PMID: 8982371     DOI: 10.1002/(SICI)1096-9098(199612)63:4<256::AID-JSO8>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

Review 1.  [Cryoablation of localized prostate cancer. Current state].

Authors:  U K F Witzsch; E Becht
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

2.  [Cryoablation of prostate cancer].

Authors:  U K F Witzsch; E Becht
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

3.  Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility.

Authors:  Farid G Mitri; Brian J Davis; Azra Alizad; James F Greenleaf; Torrence M Wilson; Lance A Mynderse; Mostafa Fatemi
Journal:  IEEE Trans Biomed Eng       Date:  2008-11       Impact factor: 4.538

4.  [Cryoablation of prostate cancer].

Authors:  U K F Witzsch; K Skriapas; E Becht
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.